Leading science, pioneering therapies
CRM Publications

Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis.

TitleCardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis.
Publication TypeJournal Article
Year of Publication2017
AuthorsRedgrave RE, Tual-Chalot S, Davison BJ, Singh E, Hall D, Amirrasouli MM, Gilchrist D, Medvinsky AL, Arthur HM
JournalStem Cell Reports
Volume8
Issue5
Pagination1287-1298
Date Published2017 May 09
ISSN2213-6711
Abstract

Clinical trials of stem cell therapy to treat ischemic heart disease primarily use heterogeneous stem cell populations. Small benefits occur via paracrine mechanisms that include stimulating angiogenesis, and increased understanding of these mechanisms would help to improve patient outcomes. Cardiosphere-derived-cells (CDCs) are an example of these heterogeneous stem cell populations, cultured from cardiac tissue. CDCs express endoglin, a co-receptor that binds specific transforming growth factor β (TGFβ) family ligands, including bone morphogenetic protein 9 (BMP9). In endothelial cells endoglin regulates angiogenic responses, and we therefore hypothesized that endoglin is required to promote the paracrine pro-angiogenic properties of CDCs. Cre/LoxP technology was used to genetically manipulate endoglin expression in CDCs, and we found that the pro-angiogenic properties of the CDC secretome are endoglin dependent both in vitro and in vivo. Importantly, BMP9 pre-treatment of endoglin-depleted CDCs restores their pro-angiogenic paracrine properties. As BMP9 signaling is normally required to maintain endoglin expression, we propose that media containing BMP9 could be critical for therapeutic CDC preparation.

DOI10.1016/j.stemcr.2017.04.015
Alternate JournalStem Cell Reports
PubMed ID28494939
PubMed Central IDPMC5425789
Publication institute
CRM